Immunoglobulin preparations are produced from human blood and contain a number of quite different antibodies (polyclonal antibodies).
Search results 1 to 25 from a total of 71
| Name | Description | Marketing Authorisation Holder | License Number | License Date | Use | Further Information |
|---|---|---|---|---|---|---|
|
Intratect |
Immunglobulin vom Menschen (IVIg) |
AxiCorp Pharma GmbH |
PEI.H.11553.01.1 | 31.05.2013 | intravenös | |
|
HyQvia |
Normales Immunglobulin vom Menschen |
Baxalta Innovations GmbH |
EU/1/13/840 | 16.05.2013 | subkutan |
Schlungsmaterial: |
|
KIOVIG |
Normales Immunglobulin vom Menschen |
Baxter AG |
EU/1/05/329/ 001-006 | 19.01.2006 | intravenös | |
|
Cytotect CP Biotest |
Cytomegalie-Ig |
Biotest Pharma GmbH |
6a/96 | 07.01.2000 | intravenös | |
|
Intratect |
Normales Immunglobulin vom Menschen |
Biotest Pharma GmbH |
PEI.H.02901.01.1 | 27.09.2004 | intravenös | |
|
Biseko |
Humanes Normalserumpräparat |
Biotest Pharma GmbH |
32a/78 | 01.08.1980 | intravenös | |
|
Fovepta 200 I.E. |
Humanes Hepatitis-B-Immunglobulin |
Biotest Pharma GmbH |
PEI.H.11536.01.1 | 28.03.2012 | intramuskulär, subkutan | |
|
Hepatect CP |
Hepatitis-B-Ig |
Biotest Pharma GmbH |
72a/96 | 18.04.2000 | intravenös | |
|
Zutectra |
Hepatitis-B-Immunglobulin vom Menschen |
Biotest Pharma GmbH |
EU/1/09/600/001 | 30.11.2009 | subkutan | |
|
Intratect, 100g/l, Infusionslösung |
Normales Immunglobulin vom Menschen (IVIg) |
Biotest Pharma GmbH |
PEI.H.11631.01.1 | 05.12.2012 | intravenös | |
|
Varitect CP |
Varicella Zoster-Ig |
Biotest Pharma GmbH |
203a/95 | 21.12.1999 | intravenös | |
|
Pentaglobin |
Immunglobulin vom Menschen |
Biotest Pharma GmbH |
170a/90 | 23.10.1990 | intravenös | |
Yimmugo 100mg/ml |
Normales Immunglobulin vom Menschen (IVIg) |
Biotest Pharma GmbH |
PEI.H.12143.01.1 | 11.11.2022 | intravenös | |
|
Intratect |
Normales Immunglobulin vom Menschen |
CC Pharma GmbH |
PEI.H.07961.01.1 | 14.09.2009 | intravenös | |
|
Intratect 100 g/l |
Normales Immunglobulin vom Menschen (IVIg) |
CC Pharma GmbH |
PEI.H.11933.01.1 | 19.07.2017 | intravenös | |
|
Tetagam P |
Tetanus-Ig |
CSL Behring GmbH |
108a/89 | 22.09.1992 | intramuskulär | |
|
Privigen |
Normales Immunglobulin vom Menschen (IVIg) |
CSL Behring GmbH |
EU/1/08/446/001-005 | 25.04.2008 | intravenös | |
|
Rhophylac 200 |
Anti-D Immunglobulin vom Menschen |
CSL Behring GmbH |
PEI.H.00399.03.1 | 05.11.2009 | intramuskulär, intravenös | |
|
Berirab |
Tollwut-Ig |
CSL Behring GmbH |
107a/89 | 22.09.1992 | intramuskulär | |
|
Beriglobin |
Immunglobulin G vom Menschen |
CSL Behring GmbH |
176a/92 | 22.09.1997 | subkutan, intramuskulär | |
|
Hepatitis-B-Immunglobulin Behring |
Hepatitis-B-Ig |
CSL Behring GmbH |
105a/89 | 22.09.1992 | intramuskulär | |
|
Rhophylac 300 |
Anti-D-Ig |
CSL Behring GmbH |
PEI.H.00399.02.1 | 15.03.2001 | intramuskulär, intravenös | |
|
Hizentra |
Normales Immunglobulin vom Menschen |
CSL Behring GmbH |
EU/1/11/687/001-012 | 14.04.2011 | subkutan | |
|
Gamunex 10% |
Normales Immunglobulin vom Menschen (IVIg) |
EMRA-MED Arzneimittel GmbH |
PEI.H.11926.01.1 | 29.05.2019 | intravenös | |
|
Rhophylac 300 |
Anti-D (Rh) Immunglobulin |
EMRA-MED Arzneimittel GmbH |
PEI.H.11954.01.1 | 30.01.2019 | intramuskulär, intravenös |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 515 in BAnz AT 09.04.2024 B3.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 09.04.2024
